4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

3 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

4 - GAXOS.AI INC. (0001895618) (Issuer)

8-K - GAXOS.AI INC. (0001895618) (Filer)

424B5 - GAXOS.AI INC. (0001895618) (Filer)

424B5 - GAXOS.AI INC. (0001895618) (Filer)

8-K - GAXOS.AI INC. (0001895618) (Filer)

10-Q - GAXOS.AI INC. (0001895618) (Filer)

8-K - GAXOS.AI INC. (0001895618) (Filer)

10-Q - GAXOS.AI INC. (0001895618) (Filer)

DEFA14A - GAXOS.AI INC. (0001895618) (Filer)

DEF 14A - GAXOS.AI INC. (0001895618) (Filer)

10-Q - GAXOS.AI INC. (0001895618) (Filer)

DENVER, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Execution is the theme this morning, as a cluster of emerging growth names move from pilot programs and strategic roadmaps into operational scale. Kraig Biocraft Laboratories Moves from Plan to Production Kraig Biocraft Laboratories (OTCQB:KBLB) announced that its 2026 production strategy has officially shifted into execution mode, with bio-material moved into incubation ahead of its March production run. The company is targeting sustained monthly 10 metric-ton-level output of recombinant spider silk cocoons, an ambitious scale-up initiative in a niche but potentially transformative advanced materials market. CEO Kim Thompson characterized the d

Preferred model pricing and cutting-edge AI accelerate Art-Gen growth and global creator adoption Roseland, NJ, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that it finalized a deal with Byteplus, the Enterprise Technology Division of ByteDance. Under the agreement, Gaxos will receive preferred pricing and significant discounts on ByteDance's cutting-edge video generation models, enabling faster deployment of AI capabilities inside Art-Gen, Gaxos' flagship AI image and video creation platform that makes pro-grade content effortless for anyone, anywh

Caylent Named Development Partner to Lead AWS-Native Build Roseland, NJ, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that Amazon Web Services ("AWS") has committed to fund the preliminary development of Gaxos Labs' innovative, AI-powered sales coaching platform, positioning Gaxos to compete in the multibillion- dollar sales technology market. The AWS-backed initiative, in collaboration with Caylent, an AWS premier partner, supports the development of a real-time, AI sales platform designed for enterprise-scale deployment, incorporating live call t

Roseland, NJ, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Bible Pray AI, a personalized, AI-powered spiritual growth platform designed to help users deepen faith, strengthen daily devotion, and apply scripture for greater peace, clarity, and purpose. Bible Pray AI represents Gaxos' strategic expansion into the rapidly growing digital faith, mental wellness, and personal development economy, a sector supported by hundreds of millions of engaged global users seeking guided spiritual content, daily motivation, and community-base

Roseland, NJ, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced its participation in the upcoming WAWTech Conference, taking place on December 16-17, 2025 in Warsaw, Poland. "We're thrilled to take part in this year's WAWTech Conference ," said Vadim Mats, CEO of Gaxos. "This event offers a tremendous opportunity to engage with technology leaders and innovators across Europe, exchange ideas, and build partnerships that accelerate the growth and adoption of Gaxos AI offerings." To meet with Gaxos at the conferences or for press inquiries, please email pre

Gaxos Labs Expands Art-Gen Platform, Unlocking New Revenue Streams in the $250B Creator Economy Roseland, NJ, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the launch of Photoshoots, a major new feature for Art-Gen, an AI image and video creation platform that makes pro-grade content effortless for anyone, anywhere.  The feature update introduces an entirely new workflow that enables users to produce consistent, cinematic, studio-quality images and animations from any photo or concept in seconds. This release strengthens Gaxos' position in the rapid

Roseland, NJ, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Art-Gen.AI, an AI image and video creation platform that makes pro-grade content effortless for anyone, anywhere. Art-Gen combines state-of-the-art AI models from industry leaders including Google, Stability AI, and PixVerse with Gaxos' proprietary enhancements to deliver unmatched creative speed, detail, and flexibility. With just a simple text prompt or reference image, users can instantly produce cinematic visuals, hyper-realistic imagery, or animated video content

Roseland, NJ, May 21, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of UnPGT.ai, a tool that makes text created by generative artificial intelligence sound natural and human. UnGPT introduces a real-time rewriting engine designed to convert machine-generated text into authentic, human-quality content without compromising meaning or context. UnGPT uses a proprietary multi-pass transformation model that outperforms leading AI detection tools and addresses one of the industry's fastest growing concerns: the need for undetectable, high-quality output in se

Roseland, NJ , May 07, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its product, Gaxos Labs for Game Developers and Publishers, has been officially approved for listing on Amazon Web Services (AWS) Marketplace, one of the cloud industry's largest software distribution platforms.  The approval marks a significant milestone in the Company's go-to-market strategy, enabling seamless deployment of Gaxos Labs by millions of AWS customers across 245 countries and territories. AWS Marketplace listing streamlines procurement for enterprise clients, simplifies software billi

Roseland, NJ, April 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of the AI-enabled Gaxos Health mobile application for iOS and Android for its customers.  The new AI-driven app is designed to personalize and optimize individual health outcomes through smart technology and science-backed routines. The Gaxos Health app leverages proprietary algorithms to deliver goal-based wellness protocols including nutrition, fitness, supplementation, and behavioral coaching. "We are thrilled to announce the launch of the Gaxos Health app," said Vadim Mats, CEO

Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

SC 13G - GAXOS.AI INC. (0001895618) (Subject)

Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce